Background On Dec 31, 2019, China reported a cluster of cases of pneumonia in people at
Wuhan, Hubei Province. The responsible pathogen is a novel coronavirus, named severe …

A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has
recently emerged to cause a human pandemic. Although molecular diagnostic tests were …

CD4 + T-cell depletion is pathognomonic for AIDS in both HIV and simian immunodeficiency
virus (SIV) infections. It occurs early, is massive at mucosal sites, and is not entirely reverted …

The characterization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral
kinetics in hospitalized patients and its association with mortality is unknown. We analyzed …

It is of paramount importance to evaluate the prevalence of both asymptomatic and symptomatic
cases of SARS-CoV-2 infection and their differing antibody response profiles. Here, we …

A new coronavirus, SARS-CoV-2, has recently emerged to cause a human pandemic. Whereas
molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet …

Background Guidelines for stopping coronavirus disease 2019 patient isolation are mainly
symptom-based, with isolation for 10 to 20 days depending on their condition. Methods In this …

In the race to contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
efficient detection and triage of infected patients must rely on rapid and reliable testing. In this …

Background Respiratory syncytial virus (RSV) is widely known as a frequent cause of respiratory
distress among adults, particularly older people. Recent years have witnessed several …

Objectives Molecular assays on nasopharyngeal swabs remain the cornerstone of COVID-19
diagnostics. The high technicalities of nasopharyngeal sampling and molecular assays, as …